These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 15607800)

  • 21. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
    Carlsten M; Björkström NK; Norell H; Bryceson Y; van Hall T; Baumann BC; Hanson M; Schedvins K; Kiessling R; Ljunggren HG; Malmberg KJ
    Cancer Res; 2007 Feb; 67(3):1317-25. PubMed ID: 17283169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.
    Pende D; Castriconi R; Romagnani P; Spaggiari GM; Marcenaro S; Dondero A; Lazzeri E; Lasagni L; Martini S; Rivera P; Capobianco A; Moretta L; Moretta A; Bottino C
    Blood; 2006 Mar; 107(5):2030-6. PubMed ID: 16304049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells.
    Vacca P; Cantoni C; Prato C; Fulcheri E; Moretta A; Moretta L; Mingari MC
    Int Immunol; 2008 Nov; 20(11):1395-405. PubMed ID: 18815119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).
    Pende D; Spaggiari GM; Marcenaro S; Martini S; Rivera P; Capobianco A; Falco M; Lanino E; Pierri I; Zambello R; Bacigalupo A; Mingari MC; Moretta A; Moretta L
    Blood; 2005 Mar; 105(5):2066-73. PubMed ID: 15536144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1.
    Seth S; Maier MK; Qiu Q; Ravens I; Kremmer E; Förster R; Bernhardt G
    Biochem Biophys Res Commun; 2007 Dec; 364(4):959-65. PubMed ID: 17971293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression.
    Pignoloni B; Fionda C; Dell'Oste V; Luganini A; Cippitelli M; Zingoni A; Landolfo S; Gribaudo G; Santoni A; Cerboni C
    J Immunol; 2016 Nov; 197(10):4066-4078. PubMed ID: 27733551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.
    Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
    Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and characterization of a novel anti-DNAM-1 monoclonal antibody.
    Yamashita Y; Abe F; Hirochika R; Tahara-Hanaoka S; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):60-4. PubMed ID: 23600509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
    Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
    Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs.
    Morimoto K; Satoh-Yamaguchi K; Hamaguchi A; Inoue Y; Takeuchi M; Okada M; Ikeda W; Takai Y; Imai T
    Oncogene; 2008 Jan; 27(3):264-73. PubMed ID: 17637752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
    Matusali G; Potestà M; Santoni A; Cerboni C; Doria M
    J Virol; 2012 Apr; 86(8):4496-504. PubMed ID: 22301152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155).
    Fuchs A; Cella M; Giurisato E; Shaw AS; Colonna M
    J Immunol; 2004 Apr; 172(7):3994-8. PubMed ID: 15034010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1.
    Deuss FA; Watson GM; Goodall KJ; Leece I; Chatterjee S; Fu Z; Thaysen-Andersen M; Andrews DM; Rossjohn J; Berry R
    J Biol Chem; 2019 Aug; 294(33):12534-12546. PubMed ID: 31253644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice.
    Nagumo Y; Iguchi-Manaka A; Yamashita-Kanemaru Y; Abe F; Bernhardt G; Shibuya A; Shibuya K
    PLoS One; 2014; 9(11):e112415. PubMed ID: 25384044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor.
    Tahara-Hanaoka S; Shibuya K; Kai H; Miyamoto A; Morikawa Y; Ohkochi N; Honda S; Shibuya A
    Blood; 2006 Feb; 107(4):1491-6. PubMed ID: 16249389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells.
    Falco M; Marcenaro E; Romeo E; Bellora F; Marras D; Vély F; Ferracci G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 2004 Jun; 34(6):1663-72. PubMed ID: 15162436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
    Cifaldi L; Doria M; Cotugno N; Zicari S; Cancrini C; Palma P; Rossi P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface NK receptors and their ligands on tumor cells.
    Moretta L; Bottino C; Pende D; Castriconi R; Mingari MC; Moretta A
    Semin Immunol; 2006 Jun; 18(3):151-8. PubMed ID: 16730454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.